Table 2. Factors related with MPR <90% obtained from 2015 data.
| Crude odds ratio (95% CI) | Adjusted odds ratio (95% CI) | ||
|---|---|---|---|
| Gender | |||
| Male | 0.955 (0.797, 1.144) | 0.942 (0.773, 1.148) | |
| Female (ref) | |||
| Age | |||
| <30 | 0.959 (0.820, 1.122) | 1.184 (0.997, 1.407) | |
| 30 - 39 | 1.079 (0.940, 1.238) | 1.216 (1.047, 1.411)a | |
| 40 - 49 (ref) | |||
| ≥50 | 0.784 (0.691, 0.889)a | 0.763 (0.665, 0.875)a | |
| National Medical Aid | |||
| Covered by NHI (ref) | |||
| National Medical Aid | 1.317 (1.167, 1.486)a | 1.318 (1.151, 1.509)a | |
| Comorbidities | |||
| No comorbidity (ref) | |||
| Alcoholic liver disease | 2.339 (1.567, 3.492)a | 1.825 (1.158, 2.879)a | |
| Chronic kidney disease | 0.741 (0.439, 1.252) | 0.806 (0.449, 1.448) | |
| Fibrosis and cirrhosis of liver | 1.568 (0.885, 2.778) | 1.524 (0.811, 2.864) | |
| Mental and behavioural disorders due to use of alcohol | 2.683 (1.602, 4.343)a | 2.156 (1.227, 3.790)a | |
| Antiretroviral therapy regimen | |||
| STR INSTI (ref) | |||
| NNRTI | 1.098 (0.930, 1.295) | 1.179 (0.996, 1.396) | |
| PI | 1.664 (1.447, 1.912)a | 1.322 (1.113, 1.571)a | |
| Non STR INSTI | 1.243 (1.051, 1.470)a | 1.792 (1.549, 2.073)a | |
aSignificant at the 5% level (P-value <0.05).
Crude odds ratio was estimated by univariate logistic regression for each variable.
Adjusted odds ratio was estimated by multivariate logistic regression with gender, age, national medical aid, comorbidities, and antiretroviral therapy.
MPR, medication possession ratio; CI, confidence interval; ref, reference; NHI, national health insurance service; STR INSTI, single tablet regimen integrase strand transfer inhibitor; NNRTI, non-nucleoside reverse-transcriptase inhibitors; PI, protease inhibitor.